MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Study of Sildenafil in Advanced Heart Failure.
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2009-08-11
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00309790
Study of Sildenafil in Patient With Heart Failure.
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2006-04-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00309816
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Study of Nesiritide in Diastolic Heart Failure.
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00309868
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
- First Posted Date
- 2006-03-28
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT00307723
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-28
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT00307736
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00302406
- Locations
- 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States
An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00302367
- Locations
- 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States
A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00302354
- Locations
- 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States
Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2013-10-22
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00302393
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2016-02-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT00302458
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath